MONROVIA, Calif., July 29 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that Barry G. Caldwell, President and Chief Executive Officer will present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference at the Millennium Broadway Hotel on Wednesday, August 5th at 4:00 pm Eastern Time.
Interested parties can access a live audio web cast of the presentation at www.staar.com. A replay of the presentation will be available at the same location.
About STAAR Surgical
STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian(R) ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDA for use in treating myopia, has received CE Marking and is sold in more than 50 countries. Collamer(R) is the brand name for STAAR's proprietary collagen copolymer lens material. More information is available at www.staar.com.
CONTACT: Investors Media
EVC Group EVC Group
Douglas Sherk, 415-896-6820 Chris Gale 646-201-5431
Mike Pollock, 415-896-6820
'/>"/>
| SOURCE STAAR Surgical Company Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Review of STAARs Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume
2. Review of STAARs Application for the Visian(R) Toric Implantable Collamer(R) Lens by FDA to Resume
3. STAAR Surgical Announces Second Quarter 2009 Earnings Release Date And Conference Call
4. Richard A. Meier Appointed to STAAR Surgical Board of Directors
5. STAAR Surgical Completes Common Stock Offering
6. STAAR Surgical Receives Japanese Clearance for the KS-Ni Preloaded IOL Injector System
7. STAAR Surgical Announces First Quarter 2009 Earnings Release Date and Conference Call
8. STAAR Surgical Reports 14% Fourth Quarter Revenue Growth
9. STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses
10. STAAR Surgical Reports 33% Third Quarter Revenue Growth
11. STAAR Surgical to Present at the Noble Financial Equity Conference
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |